These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31377635)

  • 1. Multi-level Intervention Program - A Quality Improvement Initiative to Decrease Central Line-Associated Bloodstream Infections in the Pediatric Acute and Hematology/Oncology Units.
    Santos KMB; Husain SS; Torres V; Huang CC; Jacob E
    J Pediatr Nurs; 2019; 48():106-113. PubMed ID: 31377635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results.
    Bundy DG; Gaur AH; Billett AL; He B; Colantuoni EA; Miller MR;
    Pediatrics; 2014 Dec; 134(6):e1678-85. PubMed ID: 25404721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients.
    Rinke ML; Chen AR; Bundy DG; Colantuoni E; Fratino L; Drucis KM; Panton SY; Kokoszka M; Budd AP; Milstone AM; Miller MR
    Pediatrics; 2012 Oct; 130(4):e996-e1004. PubMed ID: 22945408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central line maintenance bundles and CLABSIs in ambulatory oncology patients.
    Rinke ML; Bundy DG; Chen AR; Milstone AM; Colantuoni E; Pehar M; Herpst C; Fratino L; Miller MR
    Pediatrics; 2013 Nov; 132(5):e1403-12. PubMed ID: 24101764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid cycle development of a multifactorial intervention achieved sustained reductions in central line-associated bloodstream infections in haematology oncology units at a children's hospital: a time series analysis.
    Dandoy CE; Hausfeld J; Flesch L; Hawkins D; Demmel K; Best D; Osterkamp E; Bracke T; Nagarajan R; Jodele S; Holt J; Giaccone MJ; Davies SM; Kotagal U; Simmons J
    BMJ Qual Saf; 2016 Aug; 25(8):633-43. PubMed ID: 26608456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
    Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
    Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
    Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of central line-associated bloodstream infections in a pediatric hematology/oncology population.
    Wilson MZ; Deeter D; Rafferty C; Comito MM; Hollenbeak CS
    Am J Med Qual; 2014; 29(6):484-90. PubMed ID: 24226650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge.
    Smith TL; Pullen GT; Crouse V; Rosenberg J; Jarvis WR
    Infect Control Hosp Epidemiol; 2002 May; 23(5):239-43. PubMed ID: 12026147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent port-associated bloodstream infections: a cost and resource-utilization analysis.
    Devrim İ; Özkul MT; Çağlar İ; Oruç Y; Demiray N; Tahta N; Vergin C
    BMC Health Serv Res; 2020 Apr; 20(1):336. PubMed ID: 32316939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bringing central line-associated bloodstream infection prevention home: catheter maintenance practices and beliefs of pediatric oncology patients and families.
    Rinke ML; Chen AR; Milstone AM; Hebert LC; Bundy DG; Colantuoni E; Fratino L; Herpst C; Kokoszka M; Miller MR
    Jt Comm J Qual Patient Saf; 2015 Apr; 41(4):177-85. PubMed ID: 25977202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of Supportive Care Program to Decrease CLABSI in a Middle East Pediatric Hematology and Oncology Inpatient Unit.
    Thompson K; Shaheen M
    J Pediatr Hematol Oncol Nurs; 2023; 40(5):313-324. PubMed ID: 37920979
    [No Abstract]   [Full Text] [Related]  

  • 13. Reducing central line-associated bloodstream infections in North Carolina NICUs.
    Fisher D; Cochran KM; Provost LP; Patterson J; Bristol T; Metzguer K; Smith B; Testoni D; McCaffrey MJ
    Pediatrics; 2013 Dec; 132(6):e1664-71. PubMed ID: 24249819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.
    Kelada AS; Foster TB; Gagliano GC; Worley S; Tang A; Arakoni VA; Foster CB
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):377-383. PubMed ID: 35475427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central venous catheter bundle adherence: Kamishibai card (K-card) rounding for central-line-associated bloodstream infection (CLABSI) prevention.
    Ormsby JA; Cronin J; Carpenter J; Graham DA; Potter-Bynoe G; Vaughan AM; Weir L; Flaherty KA; Chandonnet CJ; Priebe GP; Sandora TJ
    Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1058-1063. PubMed ID: 32493532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal interventions for bundle implementation to decrease central line-associated bloodstream infections in adult intensive care units in a teaching hospital in Taiwan, 2009-2013.
    Lin WP; Chang YC; Wu UI; Hung MC; Chuang PY; Wang JT; Sheng WH; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):644-651. PubMed ID: 28888825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bundle "plus": the effect of a multidisciplinary team approach to eradicate central line-associated bloodstream infections.
    Walz JM; Ellison RT; Mack DA; Flaherty HM; McIlwaine JK; Whyte KG; Landry KE; Baker SP; Heard SO;
    Anesth Analg; 2015 Apr; 120(4):868-76. PubMed ID: 24149581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of Central-Line-Associated Bloodstream Infections With Central-Line Utilization Rate and Maintenance Bundle Compliance Among Types of PICUs.
    Affolter JT; Huskins WC; Moss M; Kuhn EM; Gedeit R; Rice TB
    Pediatr Crit Care Med; 2016 Jul; 17(7):591-7. PubMed ID: 27124562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Results of a National Intervention to Prevent Central Line-Associated Bloodstream Infection: A Pre-Post Observational Study.
    Patel PK; Greene MT; Jones K; Rolle AJ; Ratz D; Snyder A; Saint S; Chopra V
    Ann Intern Med; 2019 Oct; 171(7_Suppl):S23-S29. PubMed ID: 31569230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.